Organisation paid for research Program year 2024 Source: CMS Open Payments

Avera Health

Neither a doctor nor a teaching hospital

Research payments

$52,875

14 payments

Through program year 2024, Avera Health is reported as receiving $52,875 in research payments, across 14 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$3,608	1
2023	Research	$10,580	1
2022	Research	$27,000	3
2020	Research	$2,188	3
2019	Research	$9,500	6

Breakdown

Who paid Research payments · program years 2019–2024

Sanofi-Aventis U.S. LLC $25,000 1 payment
AstraZeneca UK Limited $14,188 2 payments
Boston Scientific Corporation $6,188 7 payments
Janssen Research & Development, LLC $5,500 2 payments
MicroVention, Inc. $2,000 2 payments

Studies the money was for Research payments · program years 2019–2024

Phase 1b treatment with combination of PARP inhibitor and KDS-1001 in platinum sensitive recurrent high grade epithelial ovarian cancer. $25,000 1 payment
A Prospective, Open-Label, Minimally Interventional Hybrid Study in the US Comparing Initiation of Breztri Maintenance versus Any Non-Triple Inhaled Therapy at Discharge after a Hospitalization for a COPD Exacerbation $14,188 2 payments
Quantify Use of Anticoagulation to improve Management of AF $5,500 2 payments
Samurai $4,000 4 payments
Smart CRT $2,188 3 payments
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis $2,000 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.